早产儿常见之问题.ppt_第1页
早产儿常见之问题.ppt_第2页
早产儿常见之问题.ppt_第3页
早产儿常见之问题.ppt_第4页
早产儿常见之问题.ppt_第5页
已阅读5页,还剩58页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

早產兒常見之問題(1),IVH (intraventricular hemorrhage): 腦室內出血 PVL (periventricular leukomalacia): 白質軟化症 ROP (retinopathy of prematurity):早產兒視網膜病變 RDS (respiratory distress syndrome): 呼吸窘迫症候群,早產兒常見之問題(2),BPD (bronchopulmonary dysplasia): 支氣管肺發育不全 NEC (necrotizing enterocolitis): 壞死性腸炎 PDA (patent ductus arteriosus): 開放性動脈導管,Gestational age estimation and birth weight classification,Infant are classified by GA as Preterm (37 weeks) Term (37-41 6/7 weeks) Postterm (42 weeks or more) Birth weight classification Normal birth weight (NBW): 2500 gm or more Low birth weight (LBW): 2500 gm Very low birth weight (VLBW): 1500 gm Extreme low birth weight (ELBW): 1000gm,Prematurity,Incidence: 5-10% Etiology: most for unknown reasons,Low socioeconomic status Malnutrition Women under age 16 or over 35 Increased maternal activity Smoking Ac. or chr. maternal illness,Multiple-gestation births Prior poor birth outcome Obstetric factors Fetal conditions Inadvertent early delivery,Problem of prematurity (1),Respiratory Respiratory distress syndrome (RDS) Apnea Bronchopulmonary dysplasia (BPD) Neurologic Intraventricular hemorrhage (IVH) Periventricular leukomalacia (PVL) Cardiovascular Hypotension Patent ductus arteriosus (PDA),Problem of prematurity (2),Hematologic Anemia Hyperbilirubinemia Nutritional Feeding problems Type, amount, and route of feeding Gastrointestinal Necrotizing enterocolitis (NEC) Metabolic Acidosis Hyper- or hypoglycemia hypocalcemia,Problem of prematurity (3),Renal Low GFR Inability to handle water, solute, and acid loads Temperature regulation Hypothermia and hyperthermia Immunologic Greater risk for infection Ophthalmologic Retinopathy of prematurity (ROP),Intraventricular hemorrhage (IVH),In premature infant : -occurs in the gelatinous subependymal germinal matrix -highly vascular area with immature blood vessels In term infant : -germinal matrix become attenuated and tissues vascular support has strengthened.,Intraventricular hemorrhage (IVH),The incidence of IVH : -6070% of 500-750 g infants -1020% of 1000-1500 g infants 8090% of cases occur between birth and the 3rd day of life ; 50% occur on the 1st day. 2040% of cases progress during the 1st week of life ; delayed hemorrhage may occur in 1015% of patients after the 1st week of life. New-onset IVH is rare after the 1st month of life regardless of birth weight.,-prematurity -RDS -Hypoxic-ischemic or hypotensive injury -reperfusion of damaged vessels -increased or decreased cerebral blood flow -reduced vascular integrity -increased venous pressure -pneumothorax -hypervolemia -hypertension,Predisposing factors for IVH :,Clinical manifestations,Diminished or absent Mono reflex Poor muscle tone Lethargy Apnea Somnolence Periods of apnea, pallor, or cyanosis Failure to suck well Abnormal eye signs Decreased muscle tone or paralysis Metabolic acidosis Shock Decreased hematocrit or its failure to increase after transfusion,Periventricular leukomalacia (PVL),A common associated cystic finding May be due to prenatal or neonatal ischemic or reperfusion injury The result of necrosis of the periventrucular white matter Damage to the corticospinal fibers in the internal capsule.,Periventricular leukomalacia (PVL),Usually asymptomatic until the neurological sequelae of white matter necrosis become apparent in later infancy as spastic diplegia. May be present at birth but usually occurs later as an early echodense phase (3-10 days of life) followed by the typical echolucent (cystic) phase (14-20 days of life).,Intraventricular hemorrhage (IVH),Grade I - Germinal matrix hemorrhage (subependymal region or less than 10% of the ventricle; 35% of IVH) Grade II - IVH with 10-50% filling of the ventricle (40% of IVH) Grade III more than 50% involvement with dilated ventricles Grade IV - IVH with extension into the parenchyma,Patent ductus arteriosus (PDA),Connect the main pulmonary trunk (or proximal left pulmonary artery) with the descending aorta, 5-10 mm distal to the origin of the left subclavian artery Arising from the distal dorsal sixth aortic arch Is well developed by the sixth week of gestational age Is more prevalent in female than male Is a frequent complication of HMD in preterm infant, in infant born at high altitudes,Normal postnatal closure,First stage : contraction and cellular migration of medial smooth muscle result functional closure commonly occurred within 12 hours in full term baby Second stage : connective tissue formation and replacement of muscle fibers with fibrosis ligmentum arteriosum Both PGE2 and PGI2 relax the ductus arteriosus,Incidence,Prematurity: inverse with GA, PDA is found in about 45 % of infant under 1750g and 80% in infants weighting 1000g Risk factor: 1.RDS and surfactant treatment 2.Fluid overload 3.Asphyxia 4.Congenital syndrome,congenital heart disease 5.High altitude,Pathophysiology,Ductal constriction is caused by multiple factors : 1. oxygen 2. the level of prostaglandin 3. available ductus muscle mass Within the first hours after birth - fall in pulmonary vascular resistance and a rise in systemic resistance if PDA opened left to right shunt(+) result in increased pulmonary blood flow ,left ventricular volume overload, increased left ventricular end-diastolic volume and pressure -CHF,Pathophysiology,Renal, mesenteric and cerebral blood flow decreased due to ductal steal These with moderate and large ducts are prone to the development of pulmonary vascular obstructive disease by 1 year of age or beyond Preterm infant may develop CHF earlier because of incomplete development of the medial musculature in the small pulmonary arterioles Among those with RDS, they may be a initial period of improvement as the pulmonary status improves,Clinical findings (Term infants ),Pulmonary vascular resistance determines the clinical manifestations: A continuous murmur is heard infrequently Large PDA has 1. bounding peripheral pulse pressure, 2. wide pulse pressure(difference between systolic and diastolic pressure) 3. hyperactive precordium: due to elevated stroke volume,Clinical findings (Term infants ),4. Hypotension particular in these of ELBW 5. Heart failure in large PDA doesnt develop until 3 to 6 weeks of age Associated with pulmonary disease ,left heart obstructive lesion and coarctation of aorta , pulmonary resistance may be high right to left shunt no murmur,Clinical findings (preterm infants),1.The same clinical sign as term baby 2.However, many preterm baby with large PDA have no murmur 3.Most will have an increased pressure,Diagnosis,Chest x ray : cardiac enlargement ,pulmonary plethora, a prominent main pulmonary artery and left atrial enlargement EKG : left ventricular hypertrophy, left atrial hypertrophy Echocardiography: 1. M-mode : normal LA : Aa ratio in infants is between 0.8-1.0, A ratio 1.2 suggests left atrial enlargement (in the absence of left ventricular failure or volume overload) 2. 2-D:PDA,Treatment,Term infants : No evidence of cardiovascular embarrassment should be followed and catheter closure or thoracoscopic or surgical diversion Digoxin and diuretics for PDA with CHF,Preterm infants,1. Ventilator support and fluid restriction 2. Indomethacin treatment produces closure in 85% of patients 3. Prophylactic administration of indomethacin early after birth in very premature infants (1250 g) decreased the incidence of PDA, CHF, IVH and possibly mortality -but not routine due to the risk of leukomalacia, decreased renal function, platelet function and NEC,Preterm infants,4.Ibuprofen(10 mg/kg) may have fewer side effect. Archives of Disease in Childhood: Fetal & Neonatal Edition. 76(3):F179-84, 1997 May. (ibuprofen did not significantly reduce mesenteric and renal blood flow velocity.) Journal of Pediatrics. 135(6):733-8, 1999 Dec. 5.Blood transfusion in anemic preterm baby diminishes the left ventricle volume overload and hasten ductus closure by increasing arterial oxygen content,Preterm infants,Early indomethacin treatment (in premature infants with respiratory distress syndrome) improves PDA closure but is associated with increased renal side effects and more severe complications and has no respiratory advantage over late indomethacin administration in ventilated, surfactant-treated, preterm infants 32 weeks gestational age. (Journal of Pediatrics. 138(2):205-11, 2001 Feb.),PDA,Coil occlusion is a safe and effective method of percutaneous closure of small to moderate-size (minimum diameter or = 4 mm) PDAs. The largest PDA that can be closed with this technique remains to be determined. Journal of Pediatrics. 130(3):447-54, 1997 Mar.,Contraindications for indomethacin,1.serum creatine 1.7 mg/dl 2.Frank renal or gastrointestinal bleeding or generalized coagulopathy 3.NEC 4.sepsis,Necrotizing enterocolitis (NEC),Necrotizing enterocolitis,1.Definition 2.Incidence 3.Pathology & Pathogenesis 4.Clinical manifestations 5.Diagnosis 6.Management 7.Complication,Definition,The most common life-threatening emergency of the gastrointestinal tract in the newborn stage. An acquired neonatal disorder characterized by various degrees of mucosal or transmural necrosis of the intestine.,Incidence,Decreased birth weight & gestational age incidence & fatility Rare in term infants. Overall mortality 20 40%. Neonatal ICU 1 5 % No association with or race. Occures sporadically or in epidemic clusters. Most involved the distal part of the ileum and the proximal segment of colon.,Pathology & Pathogenesis (1),Cause : remains unclear but is multifactorial. No proven cause has been estabilished. The greatest risk Premature Interactions between mucosal injury (ischemia, infection, inflammation) and the hosts response to the injury (circulatory, immunologic, inflammatory),Pathology & Pathogenesis (2),Clustering of the cases infectious agent (E. Coli., Klebisella, Enterobacter, Salmonella, Coronavirus, Rotavirus, Enterovirus) No pathogen is identified. Rarely occures before enteral feeding. Much less common in infants fed human milk. Triad intestinal ischemia, oral feeding, pathogenic organisms,Initial ischemic or toxic mucosal damage Loss of mucosal integrity Enteral feedings + Bacterial proliferation Necrosis of the intestine Gas accumulation in the submucosa of bowel wall (penumatosis intestinalis) Transmural necrosis or gangrane Perforation, Sepsis, Death,Clinical manifestations,A variety of signs and symptoms and may be onset insidiously or suddenly. Usually occurs in the first 2 weeks. Age of onset is inversely relatede to the gestational age (VLBW 3 month). First signs : abdominal distension with gastric retention. 25 % bloody stool Progress maybe be rapid, but unusually to progress from mild to severe after 72 hr.,Signs and symptoms associated with necrotizing enterocolitis,Gastrointestinal Abdominal distention Abdominal tenderness Feeding intolerance Delayed gastric emptying Vomitting Occult/gross blood stool Change in stool pattern/ diarrhea Abdominal mass Erythema of abdominal wall,Systemic Lethargy Apnea/ respiratory distress Temperature instability Acidosis Glucose instability Poor perfusion/ shock DIC Positive results of blood culture,Diagnosis,A very high index of suspicion in treating infants at risk is essential. Clinical triad: Feeding intolerance, abdominal distention, grossly bloody stools. Lab studies: CBC, electrolytes, blood culture, stool screening, stool culture, Radiologic studies: 1.X-ray of abdomen: Pneumomatosis intestinalis (50-75%) Portal venous gas 2.Hepatic ultrasonography,KUB demonstrating abdominal distention, hepatic portal venous gas (arrow),and bubbly appearance of pneumatosis intestinalis (arrowhead). The latter two signs are pathognomonic for NEC.,Intestinal perforation. Cross-table abdominal roentgenogram in a patient with NEC demonstrating marked distention and massive pneumoperitoneum as evident by the free air below the anterior abdominal wall.,Management,Basic NEC protocol: 1.Nothing by mouth (NPO) 2.Use of a nasogastric tube 3.Antibiotics 4.Monitoring of vital signs & abdominal circumference 5.Removal of the umbilical catheter 6.Monitoring of fluid intake and output 7.Monitoring for gastrointestinal bleeding 8.Laboratory monitoring 9.Septic workup 10.Radiologic studies,Management by Stages,Classified by clinical syndrome (1986 Walsh and Kliegman),Stage I : Suspected NEC Systemic : Nonspecific, apnea, bradycardia, and temperature instability Gastrointestinal : Increased gastric residuals Occult blood stool Radiographic : Normal or nonspecific Treatment : NPO with antibiotics for 3 days,Stage II A Mild NEC,Systemic : Nonspecific, similar to stage 1 Gastrointestinal : Absent bowel sounds and Gross blood stools. Radiographic : Ileus with dilated loops, focal areas of pneumatosis intestinalis Treatment : NPO with antibiotics for 10-14 days,Stage II B Moderate NEC,Systemic: Mild metabolic acidosis and mild thrombocytopenia Gastrointestinal: Tenderness, abdomianl wall edema, palpable mass Radiographic: Extensive pneumatosis, portal venous gas, early ascites Treatment: Similar to stage II B,Stage III A Advanced NEC,Systemic: Hypotension, bradycardia, respiratory failure, coagulopathy severe metabolic acidosis Gastrointestinal: Spreading edema, erythema induration of the abdomen Radiographic: Prominent ascites Treatment: paracentesis, fluid resuscitation ,inotropic agent support, ventilator support,.,Stage III B Advanced NEC,Systemic : Deteriorating vital signs, shock, electrolyte imbalance Gastrointestinal : Perforation of the bowel Radiographic : Perforation of the bowel Treatment : Surgical management,Surgical management,Indication for operation: 1.Evidence of intestinal perforation 2.A spersistent, fixed senile loop 3.Erythema of the abdominal wall 4.A palpable mass 5.Brown paracentesis fluid with organisms on Gram stain 6.Failure to response to medical treatment.,Prognosis,Pneumatosis intestinal

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论